KSA ASTHMA NEWEST EXAM
2025/2026 WITH MULTIPLE CHOICE
QUESTIONS AND DETAILED
SOVLVED SOLUTIONS ALREADY
GRADED A+ AND 100% GUARANTEE
PASS (BRAND NEW EDITION!!!!)
15 minutes post bronchodilator - THE CORRECT ANSWER-A.
Budesonide/formoterol (Symbicort), with an increase in dosage
for exacerbations
A 22-year-old female presents to your office with an acute
asthma attack that developed 2 days after the onset of a viral
upper respiratory infection. Her asthma is usually well
controlled, with a personal best peak expiratory flow (PEF) of
380 L/min. On initial evaluation by the nurse she has a pulse
rate of 120 beats/min, a respiratory rate of 32/min, and an
oxygen saturation of 92% on room air. On examination she is
very dyspneic with diffuse inspiratory and expiratory wheezing
and she is using accessory muscles to breathe. Her PEF is 150
L/min. Inhaled β-agonists and systemic corticosteroids are
administered and she is reevaluated 1 hour later. Which one of
the following would provide the most reassurance that she is
responding to therapy? - THE CORRECT ANSWER-C. A PEF of 310
L/min
You are counseling a patient with moderate persistent asthma
about the value of following a written asthma action plan. To
,encourage her to use an asthma action plan you share the
results of studies that document their benefit in optimizing
asthma control and reducing future risk.
Which one of the following is an accurate statement regarding
asthma action plans? - THE CORRECT ANSWER-D. The lack of a
written asthma action plan is a risk factor for death from
asthma
A 28-year-old female presents with progressively worsening
asthma after a recent viral upper respiratory infection. When
you enter the room, she appears in distress and is only able to
talk in words, not sentences. Her respiratory rate is 34/min and
her heart rate is 126 beats/min. Her oxygen saturation before
oxygen was administered was 89%. You begin treatment with a
nebulized short-acting β-agonist (SABA) plus ipratropium and
give an initial dose of oral prednisone. After one hour her
symptoms are not responsive to initial treatment efforts.
Which one of the following should you consider as a possible
adjunctive treatment? - THE CORRECT ANSWER-C. Intravenous
magnesium sulfate
Which one of the following is true regarding regular use of
inhaled corticosteroids (ICSs) in patients with persistent
asthma? - THE CORRECT ANSWER-A. Oral candidiasis is a potential
side effect of ICS use
You have recently opened a new practice in western North
Carolina. In your first week of seeing patients, a 17-year-old
male reports that his asthma is usually worse in the early
spring.
, Which one of the following is most likely triggering his
symptoms at that time of year? - THE CORRECT ANSWER-A. Tree
Pollen
A 14-year-old female presents with a recent history of cough
and shortness of breath with exercise. Baseline pulmonary
function testing reveals an FEV1 of 3.1 L and a peak expiratory
flow of 600 L/min. Exercise testing is scheduled.
If measured within 30 minutes of exercise, which one of the
following FEV1 values would support a diagnosis of mild
exercise-induced bronchospasm in this patient? - THE CORRECT
ANSWER-B. 2.8L
A 14-year-old female with a history of asthma presents to your
office for follow-up. Her mother reports that the patient has
become increasingly agitated during the day and has frequent
nightmares, which she never had before. When asking about
any other changes to her routine, family stressors, or
medication changes you learn that she was seen by an allergy
specialist 2 months ago and was given a new prescription to
help with her asthma management. Her mother cannot recall
the name of this new medication and it is not in your electronic
medical record.
Which one of the following asthma medications is most likely to
have precipitated these symptoms? - THE CORRECT ANSWER-D.
Montelukast (Singulair)
A 35-year-old male who was admitted to the intensive-care unit
with a severe asthma exacerbation has failed to improve with
aggressive bronchodilator therapy and systemic corticosteroid
therapy. For the past 10 minutes he has appeared more
fatigued, but less wheezing is heard and his pulsus paradoxus,
2025/2026 WITH MULTIPLE CHOICE
QUESTIONS AND DETAILED
SOVLVED SOLUTIONS ALREADY
GRADED A+ AND 100% GUARANTEE
PASS (BRAND NEW EDITION!!!!)
15 minutes post bronchodilator - THE CORRECT ANSWER-A.
Budesonide/formoterol (Symbicort), with an increase in dosage
for exacerbations
A 22-year-old female presents to your office with an acute
asthma attack that developed 2 days after the onset of a viral
upper respiratory infection. Her asthma is usually well
controlled, with a personal best peak expiratory flow (PEF) of
380 L/min. On initial evaluation by the nurse she has a pulse
rate of 120 beats/min, a respiratory rate of 32/min, and an
oxygen saturation of 92% on room air. On examination she is
very dyspneic with diffuse inspiratory and expiratory wheezing
and she is using accessory muscles to breathe. Her PEF is 150
L/min. Inhaled β-agonists and systemic corticosteroids are
administered and she is reevaluated 1 hour later. Which one of
the following would provide the most reassurance that she is
responding to therapy? - THE CORRECT ANSWER-C. A PEF of 310
L/min
You are counseling a patient with moderate persistent asthma
about the value of following a written asthma action plan. To
,encourage her to use an asthma action plan you share the
results of studies that document their benefit in optimizing
asthma control and reducing future risk.
Which one of the following is an accurate statement regarding
asthma action plans? - THE CORRECT ANSWER-D. The lack of a
written asthma action plan is a risk factor for death from
asthma
A 28-year-old female presents with progressively worsening
asthma after a recent viral upper respiratory infection. When
you enter the room, she appears in distress and is only able to
talk in words, not sentences. Her respiratory rate is 34/min and
her heart rate is 126 beats/min. Her oxygen saturation before
oxygen was administered was 89%. You begin treatment with a
nebulized short-acting β-agonist (SABA) plus ipratropium and
give an initial dose of oral prednisone. After one hour her
symptoms are not responsive to initial treatment efforts.
Which one of the following should you consider as a possible
adjunctive treatment? - THE CORRECT ANSWER-C. Intravenous
magnesium sulfate
Which one of the following is true regarding regular use of
inhaled corticosteroids (ICSs) in patients with persistent
asthma? - THE CORRECT ANSWER-A. Oral candidiasis is a potential
side effect of ICS use
You have recently opened a new practice in western North
Carolina. In your first week of seeing patients, a 17-year-old
male reports that his asthma is usually worse in the early
spring.
, Which one of the following is most likely triggering his
symptoms at that time of year? - THE CORRECT ANSWER-A. Tree
Pollen
A 14-year-old female presents with a recent history of cough
and shortness of breath with exercise. Baseline pulmonary
function testing reveals an FEV1 of 3.1 L and a peak expiratory
flow of 600 L/min. Exercise testing is scheduled.
If measured within 30 minutes of exercise, which one of the
following FEV1 values would support a diagnosis of mild
exercise-induced bronchospasm in this patient? - THE CORRECT
ANSWER-B. 2.8L
A 14-year-old female with a history of asthma presents to your
office for follow-up. Her mother reports that the patient has
become increasingly agitated during the day and has frequent
nightmares, which she never had before. When asking about
any other changes to her routine, family stressors, or
medication changes you learn that she was seen by an allergy
specialist 2 months ago and was given a new prescription to
help with her asthma management. Her mother cannot recall
the name of this new medication and it is not in your electronic
medical record.
Which one of the following asthma medications is most likely to
have precipitated these symptoms? - THE CORRECT ANSWER-D.
Montelukast (Singulair)
A 35-year-old male who was admitted to the intensive-care unit
with a severe asthma exacerbation has failed to improve with
aggressive bronchodilator therapy and systemic corticosteroid
therapy. For the past 10 minutes he has appeared more
fatigued, but less wheezing is heard and his pulsus paradoxus,
